# F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

> **NCT00721799** · PHASE2 · COMPLETED · sponsor: **University of Iowa** · enrollment: 33 (actual)

## Conditions studied

- Mouth Neoplasms
- Oropharyngeal Neoplasms
- Laryngeal Neoplasms
- Head and Neck Neoplasms

## Interventions

- **DRUG:** 18F-Fluorothymidine PET scan

## Key facts

- **NCT ID:** NCT00721799
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-01
- **Primary completion:** 2014-12-31
- **Final completion:** 2014-12-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-08-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721799, "F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00721799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*